Moreover, FGFR2 expression was significantly associated with tumor stemness and EMT markers, including CD133, CD44, VIM, and N-cadherin (Figure 7N), underscoring the role of the SFRP1-FGFR2 interaction in CRLM. This evidence concerns the gene CD44 and neoplasm.